Theriva Biologics Announces Pricing of $2.5 Million Public Offering
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s[...]
09/27/2024 | Press release | Distributed by Public on 09/26/2024 19:11
Please select the service you want to use:
Smartlinks | Ministry for Health and Welfare of the Republic of Korea | Prime Minister’s Office of the Republic of Korea | News | Health | Biotechnology | Medical Technology | Healthcare Policy | Healthcare Equipment and Services | Technology | Biotechnology | Medical Technology | Science | Biotechnology | Research | Politics and Policy | Healthcare Policy | Policy and Regulation | Government | National Government | Manufacturing | Departments of Health
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact